TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0260
+0.0030 (13.04%)
May 6, 2026, 3:02 PM AEST
TrivarX Market Cap
TrivarX has a market cap or net worth of 30 million as of May 6, 2026. Its market cap has increased by 275.75% in one year.
Market Cap
30.00M
Enterprise Value
26.67M
Revenue
-95.36K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 30.00M, an increase of 159.28%. That is a compound annual growth rate of 3.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 26.53M | 21.05% |
| Dec 31, 2025 | 21.92M | 194.71% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Doctor Care Anywhere Group | 58.66M |
| PharmX Technologies | 58.03M |
| Emyria | 40.33M |
| Beamtree Holdings | 34.88M |
| Vitasora Health | 31.03M |
| Pathkey.AI | 30.35M |
| PainChek | 30.31M |
| Resonance Health | 22.90M |